Santen Pharmaceutical
4536.T
A$17.57
Share price
0.91%
Change (1 day)
13.64%
Change (1 year)
Categories
Earnings for Santen Pharmaceutical (4536.T)
Earnings in 2024 (TTM): A$0.34 Billion
According to Santen Pharmaceutical 's latest financial reports the company's current earnings are A$2.06 Billion. In 2023 the company made an earning of A$0.44 Billion, an increase over its 2022 earnings that were of A$41.92 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Santen Pharmaceutical from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | A$0.34 B | -22.36% |
| 2023 | A$0.44 B | 953.61% |
| 2022 | A$41.92 M | -74.21% |
| 2021 | A$0.16 B | -65.15% |
| 2020 | A$0.46 B | -18.3% |
| 2019 | A$0.57 B | -4.4% |
| 2018 | A$0.59 B | 22.67% |
| 2017 | A$0.48 B | 0.79% |
| 2016 | A$0.48 B | -55.86% |
| 2015 | A$1.09 B | 165.17% |
| 2014 | A$0.41 B | -3.64% |
| 2013 | A$0.42 B | -11.73% |
| 2012 | A$0.48 B | -19.7% |
| 2011 | A$0.60 B | 28.74% |
| 2010 | A$0.46 B | 1.59% |
| 2009 | A$0.46 B |